An integrative description of Euscorpius diagorasi sp. n. from Rhodes, Greece (Scorpiones: Euscorpiidae)

  An integrative description of Euscorpius diagorasi sp. n. from Rhodes, Greece (Scorpiones: Euscorpiidae) Abstract The genus  Euscorpius  Thorell, 1876 comprises a diverse and taxonomically challenging group of scorpions in the Mediterranean, with Greece representing one of its principal centers of diversity. In this study, we provide an integrative description of  Euscorpius diagorasi   sp. n. , a new species from Rhodes Island, Greece. The new species is described on the basis of adult male and female morphology and mitochondrial COI sequence data. It is a small oligotrichous species characterized by a total length of approximately 21–25 mm, pale yellow to light brown coloration with darker reddish-brown pedipalps, pectinal tooth count of 8 in the male and 7 in the females, Pv = 7–8, Pe-et = 5–6, and a distinct mitochondrial lineage. Phylogenetic analyses based on COI recovered the Rhodian specimens as a strongly supported monophyletic lineage, sister to...

A review on inflammation modulating venom proteins/peptide therapeutics and their delivery strategies: A review

 


A review on inflammation modulating venom proteins/peptide therapeutics and their delivery strategies: A review

Abstract

Inflammation is an initial biological reaction that occurs in response to infection caused by foreign pathogens or injury. This process involves a tightly controlled series of signaling events at the molecular and cellular levels, with the ultimate goal of restoring tissue balance and protecting against invading pathogens. Malfunction in the process of inflammation can result in a diverse array of diseases, such as cardiovascular, neurological, and autoimmune disorders. Therefore, the management of inflammation is of utmost importance in modern medicine. Nonsteroidal anti-inflammatory drugs (NSAIDs) and corticosteroids have long been the mainstays of pharmacological treatment for inflammation, effectively alleviating symptoms in many patients. Recently, toxins and venom, formerly seen as mostly harmful to the human body, have been recognized as possible medicinal substances for treating inflammation. Organisms that are venomous, such as spiders, scorpions, snakes, and certain marine species, have developed a wide range of powerful toxins that can effectively disable or discourage predators. Remarkably, the majority of these poisons and venoms consist of proteins and peptides, which are acknowledged as significant bioactive compounds with medicinal potential. The goal of this review is to investigate the medicinal potential of peptides derived from venoms and their complex mechanism of action in suppressing inflammation. This review also discusses various challenges and future prospects for effective venom delivery.

Hemajha, L., Singh, S., Biji, C. A., Balde, A., Benjakul, S., & Nazeer, R. A. (2024). A review on inflammation modulating venom proteins/peptide therapeutics and their delivery strategies: A review. International Immunopharmacology, 142, 113130. https://doi.org/10.1016/j.intimp.2024.113130